Zhang's team70 discovered that YTHDF1 enhances HCC stemness and drug resistance via the YTHDF1–m6A–NOTCH1 epigenetic transcription pathway, predicting HCC recurrence and poor prognosis. The gene discussed is YTHDF1; the disease is hepatocellular carcinoma.